GenKyoTex. An Innovative Approach for the Treatment of Pathologies Associated with Overproduction of Oxygen Radicals GenKyoTex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals.  Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. GenKyoTex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.